We are thrilled to announce that, following a successful year and an ever-expanding product portfolio, we’ve decided it is also time to expand our Regulatory team. Our Regulatory team ensure we deliver the highest quality pharmaceutical products to our customers and their role is absolutely key in future-proofing our business.
Rebecca Dann joins the Manx Healthcare team as a Regulatory Affairs Manager and will be dedicated to managing the Manx Healthcare Parallel Import portfolio. She brings with her a great deal of experience within the Parallel Import arena and will be responsible for maintaining and expanding the current product line.
Philip Seaton has also joined as a Regulatory Affairs Manager, assisting our Head of Regulatory Affairs in the development of new products, as well as the management of our existing product portfolio. Philip brings with him a plethora of technical expertise, including regulatory strategy, product development, registration and post-approval activities.
We are delighted to have them both onboard and look forward to working with them both in the years to come.